A carregar...
New frontiers in the treatment of systemic juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (sJIA) and its most significant complication, macrophage activation syndrome (MAS), have traditionally been treated with steroids and non-steroidal anti-inflammatory medications. However, the introduction of biologic medications that inhibit specific cytokines,...
Na minha lista:
| Publicado no: | F1000Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
F1000Research
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482342/ https://ncbi.nlm.nih.gov/pubmed/28690841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.11327.1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|